CX Institutional Invests $105,000 in Teleflex Incorporated (NYSE:TFX)

CX Institutional purchased a new stake in shares of Teleflex Incorporated (NYSE:TFX) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor purchased 760 shares of the medical technology company’s stock, valued at approximately $105,000.

Several other hedge funds also recently added to or reduced their stakes in TFX. T. Rowe Price Investment Management Inc. grew its holdings in shares of Teleflex by 4.4% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company’s stock worth $1,098,693,000 after purchasing an additional 261,279 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Teleflex by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company’s stock valued at $202,161,000 after acquiring an additional 8,307 shares in the last quarter. Cooke & Bieler LP boosted its holdings in shares of Teleflex by 22.1% in the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock valued at $191,962,000 after purchasing an additional 195,150 shares during the period. Invesco Ltd. increased its holdings in Teleflex by 48.1% during the 4th quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company’s stock worth $190,188,000 after purchasing an additional 347,003 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its holdings in shares of Teleflex by 38.1% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 590,529 shares of the medical technology company’s stock worth $105,102,000 after buying an additional 162,950 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Teleflex Price Performance

TFX stock opened at $121.09 on Tuesday. The business’s 50-day moving average is $126.61 and its two-hundred day moving average is $151.62. The firm has a market capitalization of $5.35 billion, a P/E ratio of 24.07, a P/E/G ratio of 1.73 and a beta of 1.10. Teleflex Incorporated has a 1 year low of $118.70 and a 1 year high of $249.91. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.88 by $0.03. The business had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company’s revenue was down 5.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.21 EPS. Analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Tuesday, May 20th. This represents a $1.36 annualized dividend and a dividend yield of 1.12%. Teleflex’s dividend payout ratio (DPR) is 42.90%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Raymond James lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Wall Street Zen lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Mizuho set a $155.00 price objective on Teleflex in a report on Wednesday, April 16th. Citizens Jmp cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. Finally, Morgan Stanley dropped their price target on Teleflex from $191.00 to $173.00 and set an “overweight” rating on the stock in a research note on Monday, May 5th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $164.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.